Press release
Sialorrhea Market Size by Growth Rate, Business Challenges, Competitors, and Forecast 2033 | Emergen Research
According to the World Health Organization (WHO), nearly 50 million people worldwide are affected by dementia, with 10 million new cases emerging annually. Around 6.1 million people globally have Parkinson's disease, and ALS cases are gradually increasing at a rate of 1.5 to 2 cases per 100,000 individuals each year. The primary cause of sialorrhea in Parkinson's disease is the reduced ability to swallow due to muscle rigidity, leading to excessive saliva accumulation. As these conditions become more common, demand for effective sialorrhea treatments is expected to rise.
Download Free Exclusive Sample PDF@https://www.emergenresearch.com/request-sample/3551
Aging Population and Awareness Driving Growth
The growing geriatric population and increased awareness about sialorrhea diagnosis are also fueling market expansion. The global population aged 65 and older is expected to rise from 761 million in 2021 to 1.6 billion by 2050. Older individuals are more likely to develop neurodegenerative conditions, increasing the demand for treatments.
Additionally, heightened awareness among healthcare professionals and patients is leading to early diagnosis and treatment. Medical experts are increasingly recognizing sialorrhea as a condition that affects the quality of life, leading to its inclusion in clinical guidelines. This trend is encouraging more patients to seek treatment options, further accelerating market growth.
Growing Demand for Oral Gels and Liquid Formulations
One of the key drivers of the market is the rising demand for oral gels and liquid medications, which help manage excessive saliva production. With an increasing number of patients requiring treatment, pharmaceutical companies are investing in expanding manufacturing capacity for these essential drugs.
Currently, glycopyrrolate oral solution is the only FDA-approved anticholinergic medication for sialorrhea in children aged 3 to 16. Other commonly used treatments include atropine eye drops and scopolamine patches. Leading pharmaceutical companies are focusing on research and development to improve existing formulations and introduce new, more effective treatment options.
Challenges: Alternative Treatments Impacting Market Growth
Despite market growth, the availability of alternative therapies such as acupuncture, herbal remedies, and salivary stimulants poses a challenge. These alternatives attract some patients and healthcare providers, limiting the adoption of traditional pharmaceutical treatments. Additionally, many alternative therapies lack strong scientific evidence or regulatory approval, making it crucial for pharmaceutical companies to highlight the benefits of conventional treatment options.
Interested in knowing more relevant information? Click here:https://www.emergenresearch.com/industry-report/sialorrhea-market
Hospital Pharmacies Leading Distribution, Online Pharmacies Gaining Momentum
By distribution channel, hospital pharmacies dominated the market in 2023, accounting for the largest revenue share. Hospitals provide specialized medications with lower chances of expiration, making them a preferred choice for patients. Reports indicate that nearly 26% of hospitals operate their own pharmacies, further strengthening the segment.
However, online pharmacies are projected to grow at the highest CAGR during the forecast period. The convenience of ordering medications from home, often at competitive prices, is driving demand. A recent survey found that 52% of American adults had used an online pharmacy in 2023, with 61% purchasing most or all of their prescription drugs through digital platforms. This trend is expected to boost online sales in the coming years.
Sialorrhea Market Top Companies and Competitive Landscape
Multiple companies operating in this market are increasing the research of sialorrhea drugs. Pfizer Inc., F. Hoffmann-La Roche Ltd, Mylan N.V., and Fresenius Kabi AG are some key companies to watch for innovation in the sialorrhea market. By concentrating on growth methods, including collaborations, mergers and acquisitions, product launches, and others, companies in the sialorrhea market are attempting to increase their market share.
In February 2023, Proveca Pharma Ltd, a pharmaceutical business that specializes in paediatric medications, supplied Sialanar (glycopyrronium bromide) to children in France who had severe sialorrhea due to long-term neurological conditions.
Some of the key companies in the global Sialorrhea market include:
Pfizer Inc
Hoffmann-La Roche Ltd
Mylan N.V.
Fresenius Kabi AG
Hikma Pharmaceuticals PLC
Novartis AG
Teva Pharmaceutical Industries Ltd.
Bristol Myers Squibb Company
GSK Plc.
Bayer AG
Sun Pharmaceutical Industries Ltd
Merz Pharma
USWM, LLC.
Sialorrhea Market Latest Industry Updates
In March 2022, Proveca Pharma Ltd. and ExCEEd Orphan announced their collaboration to market and distribute Sialanar, a drug used to treat severe sialorrhea in children and teenagers. The rights cover eight nations in Central and Eastern Europe (CEE): Bulgaria, Croatia, the Czech Republic, Hungary, Poland, Romania, Slovakia, and Slovenia.
In August 2021, Merz Therapeutics, received approval to use XEOMIN to treat the symptoms of chronic sialorrhea in age group between 7 to 12 weigh more than 12 kg and have neurodevelopmental disorders or neurological conditions at the EU level. It received approval from the Russian Federal Service for Surveillance in Healthcare in August 2021 and US FDA in december 2020.
Make Payment [Buy your Exclusive copy] @ https://www.emergenresearch.com/select-license/3551
The main report offers detailed historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the segments from 2020 to 2033:
Sialorrhea Market Segmentation Analysis
By Type Outlook (Revenue, USD Million; 2020-2033)
Anterior Sialorrhea
Posterior Sialorrhea
By Drugs Outlook (Revenue, USD Million; 2020-2033)
RimabotulinumtoxinB
IncobotulinumtoxinA
Others
By Distribution Channel Outlook (Revenue, USD Million; 2020-2033)
Online Pharmacy
Retail Pharmacy
Hospital Pharmacy
By End User Outlook (Revenue, USD Million; 2020-2033)
Specialty Clinics
Hospitals
Homecare
Others
By Regional Outlook (Revenue, USD Million; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Request Customization in The Report @ https://www.emergenresearch.com/request-for-customization/3551
Look Over transcripts provided by Emergen Research
Sialorrhea Market Size @https://www.emergenresearch.com/industry-report/sialorrhea-market/market-size
Sialorrhea Market Share @https://www.emergenresearch.com/industry-report/sialorrhea-market/market-share
Sialorrhea Market Trends @https://www.emergenresearch.com/industry-report/sialorrhea-market/market-trends
Sialorrhea Regional Market Demand @https://www.emergenresearch.com/industry-report/sialorrhea-market/regional-market-demand
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sialorrhea Market Size by Growth Rate, Business Challenges, Competitors, and Forecast 2033 | Emergen Research here
News-ID: 3845930 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Sialorrhea
Sialorrhea Treatment Market Size Report 2034: Major Companies, Emerging Drugs, C …
DelveInsight's "Sialorrhea Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of Sialorrhea epidemiology, market, and clinical development in Sialorrhea. In addition to this, the report provides historical and forecasted epidemiology and market data as well as a detailed analysis of the Sialorrhea market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Discover which therapies are expected to…
Chronic Sialorrhea Market to Rise as Neurological Treatment Innovations Advance …
📊 Chronic Sialorrhea Market Snapshot 2025-2032
Chronic Sialorrhea Market is projected to reach USD 672 Million by 2032, with a CAGR of 6.1% during the forecast period 2025 to 2032.
Coherent Market Insights unveils its latest data-driven Chronic Sialorrhea Market Research Report featuring transformative insights into the U.S. Chronic Sialorrhea Market. Spanning from 2025 to 2032, this report offers granular forecasts, payer-provider models, and supply chain intelligence. As the U.S. healthcare ecosystem…
Chronic Sialorrhea Market Size Forecasted To Achieve 0.97 Billion By 2029 With S …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Chronic Sialorrhea Market Size and Projected Growth Rate?
The market size for chronic sialorrhea has significantly expanded over the recent past. Its projected growth is from $0.72 billion in 2024 to an elevated figure of $0.76 billion in 2025, with a CAGR of 6.5%. Factors such as an increased…
Sialorrhea Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical …
(Albany, USA) DelveInsight's "Sialorrhea Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of Sialorrhea epidemiology, market, and clinical development in Sialorrhea. In addition to this, the report provides historical and forecasted epidemiology and market data as well as a detailed analysis of the Sialorrhea market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
The Sialorrhea market report…
Global Chronic Sialorrhea Market Projected to Surpass $0.97 Billion by 2029 with …
What combination of drivers is leading to accelerated growth in the chronic sialorrhea market?
The increasing prevalence of neurodegenerative disorders is expected to drive the growth of the chronic sialorrhea market. Neurodegenerative diseases like Parkinson's disease and amyotrophic lateral sclerosis (ALS) lead to progressive neuron degeneration, and a common complication is chronic sialorrhea (excessive drooling). As these diseases become more prevalent, particularly with the aging population, treatments to manage chronic sialorrhea…
Sialorrhea Treatment Market Global Rising Demand & Huge Scope Till 2030
A new market study report by The Insight Partners on the Sialorrhea Treatment Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period.
Get PDF Sample Report +…
